_Hello all readers, today we are going to talk about Desmoglein-1. This is a very broad and relevant topic today, covering a wide variety of aspects ranging from _aspect1 to _aspect2. Desmoglein-1 is a very influential figure in the _tema1 field and his legacy has left its mark on _tema2. Throughout history, Desmoglein-1 has been the object of controversy and admiration, generating debates and reflections that have transcended time. Therefore, it is important to delve into its origins, impact and meaning, to better understand its importance in _tema3 and _tema4. In this article we will explore the different nuances of Desmoglein-1 and how it has marked a before and after in _tema5. Stay tuned for the following lines to discover more about this exciting topic._
Desmoglein-1 is a protein that in humans is encoded by the DSG1gene.[5][6] Desmoglein-1 is expressed everywhere in the skin epidermis, but mainly it is expressed in the superficial upper layers of the skin epidermis.[7]
Deficiency of the desmoglein-1 protein has been found to be associated with increased expression of multiple genes encoding allergy-related cytokines.[9] Desmoglein-1 is haploinsufficient and a mutation in the gene can cause the autosomal dominant mutation striate palmoplantar keratoderma.[10] In 2013,[9] cases have arisen where the homozygous loss of the desmoglein-1 gene has resulted in a rare syndrome known as SAM syndrome – severe dermatitis, multiple allergies, and metabolic wasting.[11]
^Has C, Jakob T, He Y, Kiritsi D, Hausser I, Bruckner-Tuderman L (January 2015). "Loss of desmoglein 1 associated with palmoplantar keratoderma, dermatitis and multiple allergies". The British Journal of Dermatology. 172 (1): 257–61. doi:10.1111/bjd.13247. PMID25041099. S2CID42320016.
^Besco JA, Hooft van Huijsduijnen R, Frostholm A, Rotter A (October 2006). "Intracellular substrates of brain-enriched receptor protein tyrosine phosphatase rho (RPTPrho/PTPRT)". Brain Research. 1116 (1): 50–7. doi:10.1016/j.brainres.2006.07.122. PMID16973135. S2CID23343123.
Further reading
Amagai M (February 2003). "Desmoglein as a target in autoimmunity and infection". Journal of the American Academy of Dermatology. 48 (2): 244–52. doi:10.1067/mjd.2003.7. PMID12582396.
Amagai M, Klaus-Kovtun V, Stanley JR (November 1991). "Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion". Cell. 67 (5): 869–77. doi:10.1016/0092-8674(91)90360-B. PMID1720352. S2CID21647774.
Martínez RD (1992). "" [Characterization of the desmoglein in renal cells in culture]. Revista Alergia Mexico (in Spanish). 38 (2): 59–64. PMID1754823.
Nilles LA, Parry DA, Powers EE, Angst BD, Wagner RM, Green KJ (August 1991). "Structural analysis and expression of human desmoglein: a cadherin-like component of the desmosome". Journal of Cell Science. 99 ( Pt 4) (4): 809–21. doi:10.1242/jcs.99.4.809. PMID1770008.
Simrak D, Cowley CM, Buxton RS, Arnemann J (January 1995). "Tandem arrangement of the closely linked desmoglein genes on human chromosome 18". Genomics. 25 (2): 591–4. doi:10.1016/0888-7543(95)80067-V. PMID7790000.
Wang Y, Amagai M, Minoshima S, Sakai K, Green KJ, Nishikawa T, Shimizu N (April 1994). "The human genes for desmogleins (DSG1 and DSG3) are located in a small region on chromosome 18q12". Genomics. 20 (3): 492–5. doi:10.1006/geno.1994.1207. PMID8034325.
Schäfer S, Koch PJ, Franke WW (April 1994). "Identification of the ubiquitous human desmoglein, Dsg2, and the expression catalogue of the desmoglein subfamily of desmosomal cadherins". Experimental Cell Research. 211 (2): 391–9. doi:10.1006/excr.1994.1103. PMID8143788.